Golden Eye Pharma Private Limited
About Golden Eye Pharma Private Limited
Data last updated:
Golden Eye Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 13 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U33100RJ2019PTC063977. Its GSTIN is 08AAHCG6840J1ZA (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gunja Kumari and Kishor Kumar Jangir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 26 Agroha Heritage Central Spine Vidyadhar Nagar, Jaipur, Rajasthan, India – 302023.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.53 Lakh. For the same year it recorded a net profit of ₹1.1 Lakh (net margin 31.1%) and EBITDA of ₹1.1 Lakh (EBITDA margin 31.1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 35% over five years.
Company details
Contact details
Golden Eye Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressG – 26 Agroha Heritage Central Spine Vidyadhar Nagar, Jaipur, Rajasthan, India – 302023
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
To see the full contact details of Golden Eye Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Golden Eye Pharma Private Limited
FY 2025 filings availableGolden Eye Pharma Private Limited reported revenue of ₹3.53 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 35% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.1% | ||||
| Net Profit Margin | 31.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Golden Eye Pharma Private Limited, buy the company report.
Board of directors of Golden Eye Pharma Private Limited
Golden Eye Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gunja Kumari | Director | 09 Sep 2020 | 6 Years 1 Months | Current |
| Kishor Kumar Jangir | Director | 13 Feb 2019 | 7 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Golden Eye Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Golden Eye Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Golden Eye Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAHCG6840J1ZA | Rajasthan | Active | 01 Apr 2019 |
To see the full GST registrations and return filing status of Golden Eye Pharma Private Limited, buy the company report.
Recent activity
Golden Eye Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Gunja Kumari ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Golden Eye Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 13 February 2019 (7+ years old) and is registered under CIN U33100RJ2019PTC063977.
Golden Eye Pharma has 2 current directors:
- Gunja Kumari - Director
- Kishor Kumar Jangir - Director
The latest financial statements of Golden Eye Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Golden Eye Pharma is 08AAHCG6840J1ZA, registered in Rajasthan.
The CIN (Corporate Identification Number) of Golden Eye Pharma is U33100RJ2019PTC063977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Golden Eye Pharma was incorporated on 13 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
Gunja Kumari ceased to be Additional Director on 31 Dec 2020. Amit Kumar Singh ceased to be Director on 10 Sep 2020. Gunja Kumari was appointed as Director on 09 Sep 2020. Golden Eye Pharma has 5 board changes on record in total.
The registered office of Golden Eye Pharma is at G – 26 Agroha Heritage Central Spine Vidyadhar Nagar, Jaipur, Rajasthan, India – 302023.
Golden Eye Pharma operates in the healthcare industry, in the manufacturing segment.
Golden Eye Pharma can be reached at its registered office: G – 26 Agroha Heritage Central Spine Vidyadhar Nagar, Jaipur, Rajasthan, India – 302023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
